- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02331524
Interventions to Improve Daily Activity in Heart Failure
Exercise and Psychosocial-Based Interventions to Improve Daily Activity in Heart Failure
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Few studies have been able to demonstrate intervention efficacy for improving daily activity in heart failure (HF). Exercise alone is ineffective, though psychosocial-based interventions including health coaching and daily activity feedback appear to be promising. Therefore, the primary purpose of the present proposed study is to investigate the effect of two different intervention approaches (1. daily activity feedback with associated encouragement, and 2. health coaching with an associated individualized home exercise program) on daily activity, exercise tolerance, HF-related health status, and lower extremity functional strength. A secondary purpose is to compare daily activity as recorded by Medtronic® implanted cardioverter defibrillator (ICDs) and cardiac resynchronization therapy (CRT) devices to daily activity recorded by a well-established triaxial accelerometer.
This will be a single-blinded randomized trial, with subject randomization stratified by age and baseline activity level. Subjects will be randomized to one of three groups: 1) A control group receiving usual care, 2) a group receiving only feedback with associated encouragement about their daily activity, and 3) an intervention group that will receive health coaching with an associated individualized home exercise program.
The study will consist of a 3 month intervention period and a 6 month follow-up/ retention period (total study enrollment period of 9 months). The primary study endpoint is Medtronic device-measured daily activity. All study endpoints will be assessed at baseline, 3 months, and 9 months. The investigators who are conducting study measurements will be blinded to group assignment.
Using a previously established minimum clinically important difference (MCID) of 1.08 hours per day for improvement in daily activity (effect size=1.54) as measured by Medtronic ICDs/CRTs, a total of 8 subjects per group would be needed to achieve a statistical power (1-β) of 0.80 (two-tailed, α=0.05) for a between-groups comparison utilizing two groups. Therefore, depending on the observed effect size in the proposed study, utilizing 3 groups with approximately 10 subjects in each group should provide adequate statistical power for a between-groups comparison with 3 groups.
Statistical analyses will be conducted to meet the planned study objectives. With regard to intervention effects, one way analysis of variance with planned contrasts will be used to examine between-group differences for each of the continuous variables [Patient Activity, Kansas City Cardiomyopathy Questionnaire (KCCQ), Patient Health Questionnaire (PHQ-9), six-minute walk test (6MWT), 30 second timed chair rise (30-s TCR), heart rate variability, Optivol Fluid Index]. If the data do not meet the requisite assumptions, the Kruskal-Wallis analysis of variance by ranks will be used. Baseline to 3 months data will be used to assess immediate intervention effects and to 9 month follow-up will be used to assess retention effects.
With regard to concurrent validity of the Medtronic Patient Activity measurement, the Pearson correlation coefficient will be calculated between the daily Patient Activity (minutes per day) and two Actigraph parameters: daily activity count and steps per day. Correlation coefficients will be calculated for the baseline, 3-month, and 9-month monitoring periods to provide a greater number of sampling days. Correlation coefficients will also be calculated for changes in daily activity measurements between baseline and 3 months and baseline and 9 months to determine concurrent validity of change in daily activity measurements.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Michigan
-
Grand Rapids, Michigan, United States, 49503
- Spectrum Health Heart and Lung Specialized Care Clinic
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Diagnosis of heart failure with subsequent placement of a Medtronic® ICD or Cardiac Resynchronization Therapy (CRT) device at least 6 months prior to study enrollment
- New York Heart Association Functional Class II to III symptoms on optimal medical therapy
Exclusion Criteria:
- Any comorbid medical disease that would prevent safe participation in an individualized exercise program such as severe osteo-, rheumatoid-, and gout-related arthritis, unstable angina, exercise-induced arrhythmias, uncontrollable diabetes, or atrial fibrillation with rapid ventricular rate in the preceding 30 days.
- Recent (<6 weeks) or planned (<6 months) major cardiovascular events or procedures
- Current participation in a regular exercise training program
- HF due to severe, uncorrected primary valvular disease, congenital heart disease, or obstructive cardiomyopathy
- Adults unable to consent (e.g. cognitively impaired), pregnant women, and prisoners
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
NO_INTERVENTION: Control/Usual Care
Usual care only
|
|
|
EXPERIMENTAL: Activity Feedback and Encouragement
Weekly Feedback about daily activity using the FitBit Zip
|
The Daily Activity Feedback/ Encouragement group will receive weekly feedback and encouragement regarding daily activity using the Fitbit Zip® for 3 months.
Visual feedback and verbal encouragement will be provided.
Visual feedback will provide graphics showing current and historical daily activity trends since the start of the intervention period.
Subjects in the Feedback group will also receive standardized verbal feedback based upon the Fitbit Zip data.
For example, subjects demonstrating a trend of increasing daily activity will be encouraged to "Continue what you are doing.
You are doing great!"
|
|
EXPERIMENTAL: Health Coaching/Home Exercise
Weekly contact from physical therapist to develop and progress home exercise program and by health coach for goal setting and support
|
The Health Coaching/Home Exercise group will receive 12 weekly health coaching and physical therapy visits for 3 months.
Health coaching will be provided by a trained, highly experienced health and wellness coach.
In-home health coaching sessions will be provided monthly (total of 3) with the remaining 9 sessions provided telephonically.
Initial health coaching sessions will include the utilization of motivational interviewing to establish individualized, three-month goals related to symptoms, function, and/or daily activity, with subsequent sessions celebrating successes in and/or identifying barriers to achieving these goals.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in Medtronic Implanted Device Patient Activity Measure
Time Frame: Change from baseline to 3 and 9 months
|
Change from baseline to 3 and 9 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in ActiGraph Daily Activity
Time Frame: Change from baseline to 3 and 9 months
|
Change from baseline to 3 and 9 months
|
|
Change in Six-Minute Walk Test
Time Frame: Change from baseline to 3 and 9 months
|
Change from baseline to 3 and 9 months
|
|
Change in 30 Second Timed Chair Rise
Time Frame: Change from baseline to 3 and 9 months
|
Change from baseline to 3 and 9 months
|
|
Change in Kansas City Cardiomyopathy Questionnaire
Time Frame: Change from baseline to 3 and 9 months
|
Change from baseline to 3 and 9 months
|
|
Change in 9 Item Patient Health Questionnaire
Time Frame: Change from baseline to 3 and 9 months
|
Change from baseline to 3 and 9 months
|
|
Change in Health Care Utilization
Time Frame: Change from baseline to 3 and 9 months
|
Change from baseline to 3 and 9 months
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 14-180-H
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Failure
-
Umeå UniversityRegion NorrbottenNot yet recruitingHeart Failure | Diastolic Heart Failure | Systolic Heart FailureSweden
-
University of Health Sciences LahoreRecruitingAcute Decompensated Heart Failure | Heart Failure, Diastolic | Heart Failure, SystolicPakistan
-
Indiana UniversityRecruitingCongestive Heart Failure | Congestive Heart Failure (CHF) | Congestive Heart Failure Chronic | Congestive Heart Failure(CHF)United States
-
Manipal UniversityUnknownHeart Failure | Decompensated Heart Failure | Acute Heart Failure | Diastolic Heart Failure | Systolic Heart FailureIndia
-
Tufts Medical CenterMetro West Medical CenterCompletedCongestive Heart Failure | Diastolic Heart Failure | Systolic Heart FailureUnited States
-
Abbott Medical DevicesCompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure With Reduced Ejection Fraction | Heart Failure NYHA Class IV | Heart Failure With Normal Ejection Fraction | Heart Failure; With Decompensation | Heart Failure...United States, Canada
-
Lakeland Regional Health Systems, Inc.RecruitingHeart Failure | Heart Failure Acute | Acute Heart Failure (AHF) | Heart Failure - NYHA II - IVUnited States
-
VA Eastern Colorado Health Care SystemNational Institute on Aging (NIA)CompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure With Reduced Ejection Fraction | Heart Failure With Preserved Ejection Fraction | Heart Failure; With Decompensation | Heart Failure,Congestive | Heart Failure AcuteUnited States
-
Eli Lilly and CompanyNot yet recruitingHeart Failure | Heart Failure, Diastolic | Heart Failure, SystolicUnited States, Japan
-
Wake Forest UniversityNational Institute on Aging (NIA)CompletedHeart Failure, Congestive | Diastolic Heart FailureUnited States
Clinical Trials on Activity Feedback and Encouragement
-
Istituto Auxologico ItalianoRecruitingHealth BehaviorItaly
-
TC Erciyes UniversityNot yet recruitingPhysical Activity | Bariatric Surgery | Quality of Recovery | Mobilization
-
Marius HenriksenCompletedRespiratory DiseaseDenmark
-
Universitätsmedizin MannheimDr. Rolf M. Schwiete FoundationRecruitingBladder Cancer | Bladder Urothelial Carcinoma | Bladder NeoplasmGermany
-
Sheffield Hallam UniversitySheffield Children's NHS Foundation TrustCompleted
-
Stanford UniversityCompletedWounds and Injuries | Sprains and Strains | Knee Injuries | Athletic InjuriesUnited States
-
Cedars-Sinai Medical CenterUnknownSurgeryUnited States
-
Duke UniversityGilead SciencesWithdrawn
-
Marius HenriksenCompletedPulmonary Disease | Cardiac Disease | Geriatric DiseaseDenmark
-
Seoul National University HospitalCompletedWomen Who Underwent Midline Incision, Gynecological SurgeryKorea, Republic of